Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

123.87
Delayed Data
As of Jun 23
 +0.74 / +0.60%
Today’s Change
87.50
Today|||52-Week Range
139.79
+21.91%
Year-to-Date

Today’s Trading

Previous close123.13
Today’s open122.83
Day’s range121.77 - 123.93
Volume444,031
Average volume (3 months)261,596
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+27.26%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+51.53%
P/E ratioNM
Price/Sales19.42
Price/Book7.59

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.90+0.87%
AXONAxovant Sciences Ltd-0.13-0.54%
ENDPEndo International P...+0.19+1.63%
MDCOMedicines Co+0.45+1.18%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts